SCHEMBL8778942

SCHEMBL8778942

C=C1c2cc(OC)ccc2CCC12CCCC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 2/20 0.44
ADRA2A P08913 4/20 0.40
SIGMAR1 Q99720 7/20 0.40
KDM1A O60341 1/20 0.40
CYP19A1 P11511 2/20 0.39
CYP11B2 P19099 2/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
MPI P34949 1/20 0.38
ADRB2 P07550 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2B P18089 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTR2C P28335 1/20 0.38
HRH1 P35367 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRK1 P41145 1/20 0.38
HTR2B P41595 1/20 0.38
HTR5A P47898 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8779124 0.82 HTR2A (0.51) METAP1SIGMAR1CYP19A1ALDH1A1HTR2C
SCHEMBL8778973 0.77 MAOA (0.56) KDM1A
SCHEMBL8778992 0.76 TDP1 (0.39) METAP1SIGMAR1KDM1A
SCHEMBL8779056 0.76 F7 (0.39) METAP1SIGMAR1KDM1ACYP19A1CYP11B2
SCHEMBL8779005 0.76 MAPT (0.33) KDM4EALDH1A1MAPT
SCHEMBL8779123 0.76 TDP2 (0.36) ADRA2AADRA2B
SCHEMBL14409344 0.75 HTR2A (0.53) METAP1SIGMAR1CYP19A1ALDH1A1HTR2C
SCHEMBL18815844 0.73 SMN1; SMN2 (0.59) METAP1SIGMAR1CYP19A1ALDH1A1MAPT
SCHEMBL12443519 0.72 METAP1 (0.54) METAP1SIGMAR1KDM1ACYP19A1CYP11B2
SCHEMBL2311211 0.72 METAP1 (0.54) METAP1SIGMAR1CYP19A1CYP11B2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed